EPS for Jiangsu Hengrui Medicine (600276.SS)

EPS in 2023 (TTM): A$0.14

According to Jiangsu Hengrui Medicine 's latest financial reports the company's current EPS (TTM) is A$0.22. In 2022 the company made an earnings per share (EPS) of A$0.13 a decrease over its 2021 EPS that were of A$0.16.

EPS history for Jiangsu Hengrui Medicine from 2002 to 2023

Annual EPS

Year	EPS	Change
2023 (TTM)	A$0.14	3.27%
2022	A$0.13	-17.1%
2021	A$0.16	-24.44%
2020	A$0.21	20.3%
2019	A$0.18	25.58%
2018	A$0.14	27.55%
2017	A$0.11	21.64%
2016	A$0.09036	13.57%
2015	A$0.07956	39.86%
2014	A$0.05689	21.33%
2013	A$0.04688	17.7%
2012	A$0.03983	25.56%
2011	A$0.03173	26.22%
2010	A$0.02513	10.3%
2009	A$0.02279	57.92%
2008	A$0.01443	11.06%
2007	A$0.01299	85.81%
2006	A$0.006992	87.94%
2005	A$0.003720	33.97%
2004	A$0.002777	29.78%
2003	A$0.002140	19.78%
2002	A$0.001786

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions